文献速递创伤与烧伤复苏、休克与脓毒症

美国一级创伤中心大规模伤亡事件中大量输血血液制品储备的局限性

Limitations of Available Blood Products for Massive Transfusion During Mass Casualty Events at US Level 1 Trauma Centers.
PubMed 文献 · Shock · 2021-01-01
一句话结论基于16家美国一级创伤中心的模拟显示:考虑血小板时,中位50例伤员(IQR 20-90)即耗竭库存血液制品,多数中心先耗尽血小板。

该研究用16家美国一级创伤中心的现有血液制品库存数据,构建离散事件仿真模型,按现代大量输血方案评估医院应对大规模伤亡事件的能力。每家中心做9000次模拟,最不严苛场景下考虑血小板时,中位50例(IQR 20-90)即无法满足血液制品需求;忽略血小板时,5家耗尽O型红细胞、6家耗尽AB型血浆、5家呈混合耗竭。结论提示一级创伤中心现有库存不足以应对大规模伤亡事件,延长保存期的非传统血液制品可能有助弥补缺口。

要点

  • 考虑血小板时,一级创伤中心中位在50例伤员(IQR 20-90)的大规模伤亡事件中即无法满足血液制品需求。
  • 忽略血小板时,5家耗尽O型红细胞、6家耗尽AB型血浆、5家呈混合耗竭。
  • 每家中心完成9000次离散事件仿真,基于历史大规模伤亡事件血液制品消耗数据建模。
  • 延长保存期的非传统血液制品可能帮助一级创伤中心应对更大规模事件的需求。

适用人群与场景

  • 美国16家一级创伤中心,基于其现有血液制品库存与历史大规模伤亡事件血液制品消耗数据建模。
  • 研究对象为大规模伤亡事件中接受大量输血方案复苏的大量输血患者;原文未提及其他纳入或排除标准。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:横断面调查数据结合离散事件仿真模型,数据来自16家美国一级创伤中心。
  • 每家中心进行9000次模拟,按现代大量输血方案指导大量输血患者复苏,并逐级提高大规模伤亡事件的 demanding 程度。
  • 最不严苛场景下,考虑血小板时,中心无法充分满足血液制品需求的中位事件规模为50例患者(IQR 20-90)。
  • 结论:假设救治能力仅受血液制品供应限制,美国一级创伤中心现有库存不足以应对大规模伤亡事件。

证据类型、等级与局限

  • 证据类型:横断面调查结合计算机离散事件仿真模型研究。
  • 局限:样本为16家美国一级创伤中心,非真实事件前瞻性验证,结果为模型估计,需前瞻性验证;原文未给出证据等级或推荐强度。

对床旁实践的改变

  • 提示一级创伤中心在大规模伤亡事件中不能假设库存充足,血小板可能是最先耗竭的成分,需提前规划替代与调配。
  • 原文提出延长保存期的非传统血液制品可能有助于满足更大规模事件的需求;结论为模型估计,不能作为决策阈值直接套用。
  • 研究假设救治能力仅受血液制品供应限制,实际救治还受人员、设备等因素影响,应用时需注意这一前提。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

INTRODUCTION: Exsanguination remains a leading cause of preventable death in traumatically injured patients. To better treat hemorrhagic shock, hospitals have adopted massive transfusion protocols (MTPs) which accelerate the delivery of blood products to patients. There has been an increase in mass casualty events (MCE) worldwide over the past two decades. These events can overwhelm a responding hospital's supply of blood products. Using a computerized model, this study investigated the ability of US trauma centers (TCs) to meet the blood product requirements of MCEs.

METHODS: Cross-sectional survey data of on-hand blood products were collected from 16 US level-1 TCs. A discrete event simulation model of a TC was developed based on historic data of blood product consumption during MCEs. Each hospital's blood bank was evaluated across increasingly more demanding MCEs using modern MTPs to guide resuscitation efforts in massive transfusion (MT) patients.

RESULTS: A total of 9,000 simulations were performed on each TC's data. Under the least demanding MCE scenario, the median size MCE in which TCs failed to adequately meet blood product demand was 50 patients (IQR 20-90), considering platelets. Ten TCs exhaust their supply of platelets prior to red blood cells (RBCs) or plasma. Disregarding platelets, five TCs exhausted their supply of O- packed RBCs, six exhausted their AB plasma supply, and five had a mixed exhaustion picture.

CONCLUSION: Assuming a TC's ability to treat patients is limited only by their supply of blood products, US level-1 TCs lack the on-hand blood products required to adequately treat patients following a MCE. Use of non-traditional blood products, which have a longer shelf life, may allow TCs to better meet the blood product requirement needs of patients following larger MCEs.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Williams J, Gustafson M, Bai Y, et al. Limitations of Available Blood Products for Massive Transfusion During Mass Casualty Events at US Level 1 Trauma Centers. Shock. 2021. PMID: 33470606. doi:10.1097/SHK.0000000000001719

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。